IPSS-R Prognostic Risk Categories/Scores*
| RISK CATEGORY | RISK SCORE |
|---|---|
| Low | >1.5 – 3 |
| Intermediate | >3 – 4.5 |
| High | >4.5 – 6 |
| Very High | >6 |
What is a high IPSS score?
The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.
What is considered high risk MDS?
The IPSS-R would classify her as having Very High Risk disease, based on a combined score of 9.0 (3.0 for blasts, 3.0 for cytogenetics, 1.5 for severe anemia, 1.0 for severe thrombocytopenia, and 0.5 for neutropenia) and would predict for a similarly poor survival length.
What is high grade MDS?
High-grade MDS patients have a mean overall survival, ranging from 9 months to 3 years. Conversely, low-grade MDS may respond well to supportive therapy, hypomethylating agents, or immunomodulating agents, giving these patients mean overall survivals of 6-12 years.
What is the R IPSS score based on?
The IPSS-R categorizes patients into 1 of 5 groups, from very low risk to very high risk, based on risk of mortality and transformation to acute myeloid leukemia (AML). This score is not dynamic and is meant to be used at the time of diagnosis only. That being said, the score does get higher with disease progression.
What is low risk MDS?
The lower risk MDS patients are defined as those having a risk of very low, low, or intermediate disease according to the IPSS-R with a score ≤3.5 points. 2. Higher-risk patients would be those with intermediate risk and >3.5 points, high, or very high risk according to this scoring system.
What is a prognostic score?
The prognostic score, formalized by Hansen [5], is defined as the predicted outcome under the control condition, reflecting baseline “risk.” It is estimated by fitting a model of the outcome in the control group and then using that model to obtain predictions of the outcome under the control condition for all …
What is the prognosis for high risk MDS?
Survival statistics for MDS
| WPSS Risk Group | Median Survival | Risk of AML (within 5 years) |
|---|---|---|
| Low | 5.5 years | 14% |
| Intermediate | 4 years | 33% |
| High | 2.2 years | 54% |
| Very high | 9 months | 84% |
Is Venclexta approved for MDS?
“We are pleased that the FDA has granted Venclexta its sixth Breakthrough Therapy Designation in recognition of its potential to improve outcomes for people with MDS in combination with azacitidine.”
How quickly can MDS progress?
The pace of progression varies. In some individuals the condition worsens within a few months of diagnosis, while others have relatively little problem for several decades. In about 50 percent of cases, MDS deteriorates into a form of cancer known as acute myeloid leukemia (AML).
What is the scoring system for MDS?
The World Health Organization (WHO) scoring system is based on 3 factors: The type of MDS based on the WHO classification (For example, certain types of MDS-SLD and MDS-del (5q) tend to have the best outlook, whereas MDS-EB tends to have the worst.)
What is the who prognostic scoring system for multiple myeloma?
The WHO prognostic scoring system (WPSS) has the advantage of being dynamic and validated throughout the disease course. The WPSS investigators studied a cohort of 426 MDS patients from Pavia, Italy and subsequently validated the prognostic scoring system in 739 patients diagnosed in Dusseldorf, Germany.
What does WPSS stand for?
WHO Prognostic Scoring System (WPSS) The World Health Organization (WHO) scoring system is based on 3 factors: The type of MDS based on the WHO classification (For example, certain types of MDS-SLD and MDS-del(5q) tend to have the best outlook, whereas MDS-EB tends to have the worst.)
What is the outlook for myelodysplastic syndromes?
But myelodysplastic syndromes (MDS) are diseases of the bone marrow. The outlook for these cancers isn’t based on the size of a tumor or whether the cancer has spread. Because of this, doctors use other factors to predict outlook and decide when to treat. Some of these factors have been combined to develop scoring systems.
